Buscar
Mostrando ítems 1-10 de 11
Fundamento e desenho do teste randomizado PAINT
(Sociedade Brasileira de Cardiologia - SBC, 2009-12-01)
BACKGROUND: We describe the rationale and design for the PercutAneous INTervention with biodegradable-polymer based paclitaxel-eluting or sirolimus-eluting versus bare stents for de novo coronary lesions - PAINT trial. ...
Fundamento e desenho do teste randomizado PAINT
(Sociedade Brasileira de Cardiologia - SBC, 2009)
FUNDAMENTO: Descrevemos as bases teóricas e o formato do "Estudo PAINT - Intervenção percutânea com stents com eluição de paclitaxel ou sirolimus em polímero biodegradável comparados com stents sem recobrimento no tratamento ...
Randomized Evaluation of Two Drug-Eluting Stents With Identical Metallic Platform and Biodegradable Polymer But Different Agents (Paclitaxel or Sirolimus) Compared Against Bare Stents: 1-Year Results of the PAINT Trial
(WILEY-LISS, 2009)
Objectives: We tested two novel drug-eluting stents (DES), covered with a biodegradable-polymer carrier and releasing paclitaxel or sirolimus, which were compared against a bare metal stent (primary objective). The DES ...
Randomized Evaluation of Two Drug-Eluting Stents With Identical Metallic Platform and Biodegradable Polymer But Different Agents (Paclitaxel or Sirolimus) Compared Against Bare Stents: 1-Year Results of the PAINT Trial
(Wiley-Blackwell, 2009-11-01)
Objectives: We tested two novel drug-eluting stents (DES), covered with a biodegradable-polymer carrier and releasing paclitaxel or sirolimus, which were compared against a bare metal stent (primary objective). the DES ...
Late clinical outcomes after implantation of drug-eluting stents coated with biodegradable polymers: 3-year follow-up of the PAINT randomised trial
(EUROPA EDITIONTOULOUSE CEDEX 6, 2012)
Aims: The long-term clinical performance of drug-eluting stents (DES) coated with biodegradable polymers is poorly known. Methods and results: A total of 274 coronary patients were randomly allocated to paclitaxel-eluting ...
Resultados clínicos de um ano do registro POLAR (Promus eluting stent registry in Latin America)
(Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista - SBHCI, 2012-03-01)
BACKGROUND: Drug-eluting stents have been used since 2002 in different patient populations aiming to achieve high success rates with low clinical and angiographic restenosis rates. With the late thrombosis adverse events ...
Mecanismos de reestenose coronária: estudo in vitro dos padrões de expressão gênica em células endoteliais e musculares lisas de artéria coronária humana
(Universidade Estadual Paulista (Unesp), 2015-04-28)
Percutaneous transluminal revascularization of coronary arteries (angioplasty) with bare-metal stents is the most widely used and successful medical intervention for treatment of coronary artery disease (CAD). However, the ...
Mecanismos de reestenose coronária: estudo in vitro dos padrões de expressão gênica em células endoteliais e musculares lisas de artéria coronária humana
(Universidade Estadual Paulista (UNESP), 2016)